Radnostix INIS
OTC INIS
$0.05 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Radnostix (INIS) Equity Income (2011 - 2013)

Updated

Radnostix (INIS) posted Equity Income of -$54,463 for FY2012, compared with -$141,642 in FY2011.

Analysis

Radnostix (INIS) Equity Income (2011 - 2013) Analysis & Trends

  • Business Quant data shows INIS's Equity Income at -$141,642 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -10.00 Mn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Radnostix 23.81 Mn 17.92 Mn 1.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 -2,746.00
Dec 31, 2012 -8,538.00
Sep 30, 2012 -13,943.00
Jun 30, 2012 -5,206.00
Mar 31, 2012 -26,776.00
Dec 31, 2011 -21,945.00
Sep 30, 2011 -43,451.00
Jun 30, 2011 -31,390.00
Mar 31, 2011 -44,856.00
API Access

Radnostix Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=INIS&period=max&api_key=YOUR_API_KEY